Table 2.
Unadjusted | Adjusted | ||||||||
Lipid parameters (mmol/L) | Groups | N | MD ± SE (%) | 95% CI | P value | N | MD ± SE (%) | 95% CI | P value |
TC | Sex difference | 543 | 1.13 ± 1.56 | −1.93, 4.18 | .470 | 542 | −0.43 ± 1.56 | −2.63, 3.48 | .784∗ |
Men | 272 | −20.99 ± 1.02 | −23.15, −18.83 | 272 | −21.80 ± 1.05 | −23.85, −19.74 | |||
Women | 271 | −22.11 ± 1.17 | −24.40, 19.82 | 270 | −21.37 ± 1.05 | −23.43, −19.31 | |||
LDL-C | Sex difference | 543 | 2.36 ± 2.34 | −2.24, 6.97 | .315 | 542 | −0.61 ± 2.36 | −5.25, 4.03 | .797† |
Men | 272 | −26.05 ± 1.44 | −28.87, −23.23 | 272 | −27.58 ± 1.59 | −30.70, −24.46 | |||
Women | 271 | −28.41 ± 1.85 | −32.04. −24.78 | 270 | −26.97 ± 1.59 | −30.10, −23.84 | |||
HDL-C | Sex difference | 543 | −2.14 ± 1.56 | −5.21, 0.93 | .171 | 542 | −5.64 ± 1.67 | −8.92, −2.36 | .001 † |
Men | 272 | 5.74 ± 1.03 | 3.32, 7.35 | 272 | 3.59 ± 1.12 | 1.38, 5.79 | |||
Women | 271 | 7.47 ± 1.18 | 5.17, 9.77 | 270 | 9.23 ± 1.13 | 7.02, 11.44 | |||
TG | Sex difference | 543 | −8.32 ± 4.00 | −16.18, −0.45 | .038 | 542 | 7.60 ± 4.24 | 0.73, 15.92 | .073† |
Men | 272 | −2.56 ± 3.38 | −9.19, 4.07 | 272 | −2.89 ± 2.85 | −8.48, 2.70 | |||
Women | 271 | −10.87 ± 2.14 | −15.06, 6.68 | 270 | −10.49 ± 2.86 | −16.10, 4.88 |
CI = confidence interval, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, MD = mean difference, N = number of participants included in the analysis, n = number of participants with the displayed lipid parameter, SBP = systolic blood pressure, SE = standard error, TC = total cholesterol, TG = triglycerides.
Adjusted for age, SBP, DBP, TC, HDL-C, TG, and starting dose of simvastatin at baseline.
Adjusted for age, SBP, DBP, LDL-C, HDL-C, TG, and starting dose of simvastatin at baseline.